Table 1. Mitochondrial respiration of β-alanine treated and untreated permeabilized cardiomyocytes.
Condition | Substrate | State 3 rate | State 4 rate | RCR | P/O ratio |
---|---|---|---|---|---|
Control | Glu-Mal | 1.0 (43.61) | 1.0 (11.03) | 1.0 (3.7) | 2.65 ± 0.2 |
β-alanine | Glu-Mal | 0.78 ± 0.08* | 0.9 ± 0.09 | 0.8 ± 0.1* | 2.24 ± 0.17* |
Control | Succinate | 1.0 (65.4) | 1.0 (15.8) | 1.0 (3.3) | 1.47 ± 0.12 |
β-alanine | Succinate | 0.98 ± 0.09 | 1.2 ± 0.1 | 0.95 ± 0.07 | 1.31 ± 0.08 |
All of the control groups were normalized to 1.0, with the actual values shown in parentheses. The control and β-alanine-treated cardiomyocytes were incubated in medium containing either 4 mM glutamate + 2 mM malate or 5 mM succinate. After a steady-state rate of state 2 respiration was observed, 1 μmol of ADP was added and the rate of state 3 respiration was determined. When ADP levels were depleted, state 4 respiration was determined
RCR respiratory control ratio. Values shown represent means ± S.E.M. of 3–4 different experiments. Asterisks denote a significant difference between the control and β-alanine-treated groups (p < 0.05). Because the experiments were performed with different preparations, all data were normalized relative to the control cells